Abstract |
We investigated the effects of beta1-adrenoceptor blockade and M2-muscarinic receptor antagonist in rabbits which have developed dilated cardiomyopathy-like changes after immunization with the peptides from the second extracellular loop of human beta1-adrenoceptor (beta1-peptide) and M2-muscarinic receptor (M2-peptide). Ten rabbits, which were immunized with beta1-peptide once a month for one year, were treated with bisoprolol and 10 rabbits, which were immunized with M2-peptide, were treated with otenzepad. Although both groups treated with receptor blockade or antagonist showed an increased titer of anti-beta1-adrenoceptor or anti-M2-muscarinic receptor antibodies, myocardial damages were markedly less than those in beta1-peptide- or M2-peptide-immunized rabbits. This study indicates that anti-beta1-adrenoceptor and anti-M2-muscarinic receptor antibodies are of pathogenic importance in the development of human dilated cardiomyopathy, and that beta- adrenoceptor blockade, bisoprolol, and M2-muscarinic receptor antagonist, otenzepad, might be clinically useful for treatment of dilated cardiomyopathy.
|
Authors | S Matsui, M L Fu |
Journal | Autoimmunity
(Autoimmunity)
Vol. 34
Issue 3
Pg. 217-20
( 2001)
ISSN: 0891-6934 [Print] England |
PMID | 11908781
(Publication Type: Journal Article)
|
Chemical References |
- Adrenergic beta-1 Receptor Antagonists
- Adrenergic beta-Antagonists
- Muscarinic Antagonists
- Receptors, Adrenergic, beta-1
- Receptors, Muscarinic
- Pirenzepine
- otenzepad
- Bisoprolol
|
Topics |
- Adrenergic beta-1 Receptor Antagonists
- Adrenergic beta-Antagonists
(pharmacology)
- Animals
- Autoimmune Diseases
(immunology, prevention & control)
- Bisoprolol
(pharmacology)
- Cardiomyopathies
(immunology, prevention & control)
- Disease Models, Animal
- Muscarinic Antagonists
(pharmacology)
- Pirenzepine
(analogs & derivatives, pharmacology)
- Rabbits
- Receptors, Adrenergic, beta-1
(immunology)
- Receptors, Muscarinic
(immunology)
|